WILMINGTON, MA — Royal DSM announced that it will phase out 1-methyl-2-pyrrolidone, commonly known as NMP, from its resins product portfolio. In this way, DSM aims to drive the highest health and safety standards and strengthen its leadership in sustainable and innovative resins.
The decision to eliminate NMP from its product portfolio is another proof point of DSM's purpose-led, performance-driven strategy, which involves a proactive product stewardship approach to reduce the presence of chemicals of concern over the coming years. By completing its phase-out by July 2020, DSM will be compliant ahead of schedule with all relevant market legislations. This NMP phase-out is part of the company’s comprehensive phase-out program of toxic chemicals, aiming to phase out all chemicals of high concern from its finished products by 2025. DSM will leverage its scientific and technological capabilities, as well as working with partners throughout the value chain, to develop sustainable alternatives to NMP that continue to offer the highest performance.